- |||||||||| Vectibix (panitumumab) / Amgen, Takeda
Trial withdrawal, Combination therapy, Surgery, Metastases: Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence (clinicaltrials.gov) - Jan 12, 2012 P3, N=0, Withdrawn, Initiation date: May 2011 --> May 2015 Not yet recruiting --> Withdrawn
- |||||||||| Vectibix (panitumumab) / Amgen, Takeda
Enrollment change, Combination therapy, Surgery, Metastases: Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence (clinicaltrials.gov) - Jan 12, 2012 P3, N=0, Withdrawn, Not yet recruiting --> Withdrawn N=800 --> 0
|